Neuren Pharmaceuticals Limited (NEU) is a biopharmaceutical company developing new drug therapies to treat multiple serious neurological disorders that emerge in early childhood and have no or limited approved treatment options. Recognising the urgent unmet need, all programs have been granted orphan drug designation in the United States.
Find out what a historical investment in Neuren Pharmaceuticals Limited would be worth today using our NEU stock calculator.
Buying NEU shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Neuren Pharmaceuticals Limited in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in NEU
What is the ticker symbol of Neuren Pharmaceuticals Limited?
The ticker symbol for Neuren Pharmaceuticals Limited is NEU.
How much is one share of NEU?
One share of NEU is valued at $20.97 as of 22 November 2026.
What is the market capitalisation of Neuren Pharmaceuticals Limited NEU?
As of 22 November 2026 Neuren Pharmaceuticals Limited has a market cap of $2.65B.
Does NEU pay dividends?
Yes, NEU does pay dividends.
What is the dividend yield for NEU?
The dividend yield for NEU is 0.72% as of 22 November 2026.
How much dividends does NEU pay?
The most recent NEU dividend distribution paid $0.15 per share on 07 October 2026.
What is the NEU ex-dividend date?
The ex-dividend date of NEU was 15 September 2026.
What is the P/E ratio of NEU?
The Price to Earnings ratio of NEU is 94.59.
What is the Earnings Per Share of NEU?
The Earnings Per Share of NEU is $0.23.
What is the 52-week high for Neuren Pharmaceuticals Limited stock?
The Neuren Pharmaceuticals Limited 52-week high stock price is $24.55.
What is the 52-week low for Neuren Pharmaceuticals Limited stock?
The Neuren Pharmaceuticals Limited 52-week low stock price is $11.00.
Can I buy NEU shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy NEU shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.